Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects Article

Kosloski, Matthew P., Zhao, Weihan, Marbury, Thomas C. et al. (2018). Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects . ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(3), 10.1128/AAC.01990-17



Open Access Industry Collaboration International Collaboration

cited authors

  • Kosloski, Matthew P.; Zhao, Weihan; Marbury, Thomas C.; Preston, Richard A.; Collins, Michael G.; Pugatch, David; Mensa, Federico; Kort, Jens; Liu, Wei

publication date

  • March 2018

published in

Digital Object Identifier (DOI)

volume

  • 62

issue

  • 3

SDG 03: Good Health and Well-being

  • true

research area